(Q35893211)

English

Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis

scientific article published in October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

Europe PubMed Central

Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

Raghunath AS

1

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Hungin AP

2

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Wooff D

3

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Childs S

4

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

language of work or name

0 references

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

733-744

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Arrest of chronic acid suppressant drug use after successful Helicobacter pylori eradication in patients with peptic ulcer disease: a six-month follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

The significance of cagA(+) Helicobacter pylori in reflux oesophagitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Effectiveness of acid suppression in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

The effect of Helicobacter pylori eradication on gastro-oesophageal reflux

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Efficacy of combination therapy of interferon-alpha with ursodeoxycholic acid in chronic hepatitis C: a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Heartburn treatment in primary care: randomised, double blind study for 8 weeks

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02172.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2004.02172.X

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

release_c3r2x6wyfjghpdqpxnh7lvif3y

1 reference

https://api.fatcat.wiki/v0/release/c3r2x6wyfjghpdqpxnh7lvif3y

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35893211&oldid=1838391010"